findmyKOL
Clinical trialNCT04171492Active, not recruitingObservational

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

SponsorBiodesix, Inc.Enrollment2,000Nodule Solitary PulmonaryNon-small Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluates the how addition of the Nodify XL2 test result impacts the clinical management of newly identified solid lung nodules assessed as low to moderate risk of cancer.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Calgary

    Calgary, Alberta, Canada

  • Mcgill University Health Centre

    Montreal, Quebec, Canada

United States
  • University of Colorado

    Aurora, Colorado, United States

  • Beth Israel Deaconess

    Boston, Connecticut, United States

  • Massachusetts General Hospital

    Boston, Connecticut, United States

  • Medstar

    Washington D.C., District of Columbia, United States

  • Indiana University

    Indianapolis, Indiana, United States

  • the Johns Hopkins University

    Baltimore, Maryland, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • the Washington University

    St Louis, Missouri, United States

  • Mount Sinai Health System

    New York, New York, United States

  • Northwell Health

    New York, New York, United States

  • the University of North Carolina

    Chapel Hill, North Carolina, United States

  • Duke University

    Durham, North Carolina, United States

  • Southeastern Research Center

    Winston-Salem, North Carolina, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • the Ohio State University

    Coulmbus, Ohio, United States

  • the Oregon Clinic

    Portland, Oregon, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Ralph H Johnson Va Medical Center

    Charleston, South Carolina, United States

  • Prisma Health

    Greenville, South Carolina, United States

  • University of Texas Southwestern

    Dallas, Texas, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

  • Virginia Commonwealth University

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Dec 2020
Primary completion
31 Dec 2025
Completion
31 Dec 2026
Last update posted
19 Sept 2025
Registered enrollment
2,000
Registry id
NCT04171492
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.